文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

低磷血症对重症患者预后的影响

[Effect of hypophosphatemia on the prognosis of critically ill patients].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论回顾性分析显示低磷血症与ICU重症患者住院时间、ICU停留时间和机械通气时间延长相关,但不能预测28天死亡率。

该研究回顾性分析2021年10月至2022年4月天津市第一中心医院ICU收治的263例重症患者,按入ICU时血清磷水平分为低磷血症组(<0.80 mmol/L,54例)和非低磷血症组(≥0.80 mmol/L,209例)。低磷血症组SOFA评分、淋巴细胞计数和感染率显著高于非低磷血症组,NLR显著低于非低磷血症组,住院时间、ICU停留时间和机械通气时间显著延长,但28天死亡率两组无显著差异。多因素Logistic回归显示APACHE II评分、CRP和NLR是影响28天死亡率的独立危险因素。ROC曲线分析显示血清磷水平对住院时间>10天、ICU停留时间>5天和机械通气时间>5天有一定预测价值。

要点

  • 低磷血症组(血清磷<0.80 mmol/L)SOFA评分6.70±3.17 vs 非低磷血症组5.64±3.59,感染率77.78%(42/54)vs 59.33%(124/209),均P<0.05。
  • 低磷血症组住院时间15(11,28)天 vs 12(6,21)天,ICU停留时间10.35±7.80天 vs 7.15±6.61天,机械通气时间3(0,12)天 vs 2(0,5)天,均P<0.05。
  • 低磷血症组28天死亡率9.26%(5/54)vs 非低磷血症组11.00%(23/209),P>0.05,无显著差异。
  • 多因素Logistic回归显示APACHE II评分(OR=1.188,95%CI 1.110-1.271)、CRP(OR=1.016,95%CI 1.007-1.026)和NLR(OR=1.002,95%CI 0.996-1.008)是28天死亡率的独立危险因素(均P<0.05)。
  • 血清磷预测住院时间>10天、ICU停留时间>5天、机械通气时间>5天的AUC分别为0.701(95%CI 0.632-0.770)、0.771(95%CI 0.691-0.852)、0.617(95%CI 0.541-0.692),均P<0.01。

适用人群与场景

  • 2021年10月至2022年4月天津市第一中心医院ICU收治的重症患者,共263例,按入ICU时血清磷水平分组。

诊断标准与关键阈值

  • 低磷血症组:入ICU时血清磷水平<0.80 mmol/L;非低磷血症组:血清磷水平≥0.80 mmol/L。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量:263例;人群:ICU重症患者;分组:低磷血症组54例(血清磷<0.80 mmol/L)vs 非低磷血症组209例(血清磷≥0.80 mmol/L)。
  • 低磷血症组SOFA评分6.70±3.17 vs 非低磷血症组5.64±3.59,淋巴细胞计数(×10⁹/L)0.99±0.54 vs 0.77±0.54,感染率77.78%(42/54)vs 59.33%(124/209),均P<0.05。
  • 低磷血症组NLR 10.67(7.08,18.02)vs 非低磷血症组12.25(7.25,21.68),P<0.05。
  • 低磷血症组住院时间15(11,28)天 vs 非低磷血症组12(6,21)天,ICU停留时间10.35±7.80天 vs 7.15±6.61天,机械通气时间3(0,12)天 vs 2(0,5)天,均P<0.05。
  • 28天死亡率:低磷血症组9.26%(5/54)vs 非低磷血症组11.00%(23/209),P>0.05。
  • 多因素Logistic回归:APACHE II评分OR=1.188(95%CI 1.110-1.271),CRP OR=1.016(95%CI 1.007-1.026),NLR OR=1.002(95%CI 0.996-1.008),均P<0.05。
  • ROC曲线:血清磷预测住院时间>10天的AUC=0.701(95%CI 0.632-0.770),预测ICU停留时间>5天的AUC=0.771(95%CI 0.691-0.852),预测机械通气时间>5天的AUC=0.617(95%CI 0.541-0.692),均P<0.01。

证据类型、等级与局限

  • 证据类型:回顾性分析;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为低磷血症对ICU重症患者住院时间、ICU停留时间和机械通气时间有一定预测价值,但不能预测28天死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the impact of hypophosphatemia on the occurrence and prognosis of critically ill patient.

METHODS: The clinical data of critically ill patients admitted to the intensive care unit (ICU) of Tianjin First Central Hospital from October 2021 to April 2022 were retrospectively analyzed. Patients were divided into hypophosphatemia group (serum phosphorus level < 0.80 mmol/L) and non-hypophosphatemia group (serum phosphorus level ≥ 0.80 mmol/L) when they were admitted to the ICU. The following variables were also collected, including gender, age, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), serum phosphorus level, serum calcium level, serum magnesium level, white blood cell count (WBC), neutrophil count (NEU), lymphocyte count (LYM), neutrophil/lymphocyte ratio (NLR), C-reactive protein (CRP), presence of infection and infection site, length of hospital stay, ICU stay, 28-day mortality, and mechanical ventilation time. Multivariate Logistic regression analysis was used to evaluate the relationship between each variable and the 28-day mortality. The receiver operator characteristic curve (ROC curve) was drawn, and the area under the ROC curve (AUC) and 95% confidence interval (95%CI) were calculated to evaluate the predictive value of serum phosphorus levels for the prognosis of ICU patients.

RESULTS: A total of 263 patients were enrolled, including 54 patients with hypophosphatemia and 209 patients without. The SOFA score, LYM level and the infection rate of patients in the hypophosphatemia group were significantly higher than those in the non-hypophosphatemia group [SOFA score: 6.70±3.17 vs. 5.64±3.59, LYM (×109/L): 0.99±0.54 vs. 0.77±0.54, infection rate: 77.78% (42/54) vs. 59.33% (124/209), all P < 0.05], the NLR was significantly lower than that of the non-hypophosphatemia group [10.67 (7.08, 18.02) vs. 12.25 (7.25, 21.68), P < 0.05]. The length of hospital stay, ICU stay, and mechanical ventilation duration in the hypophosphatemia group were significantly longer than those in the non-hypophosphatemia group [length of hospital stay (days): 15 (11, 28) vs. 12 (6, 21), length of ICU stay (days): 10.35±7.80 vs. 7.15±6.61, mechanical ventilation duration (days): 3 (0, 12) vs. 2 (0, 5), all P < 0.05]. There was no significant difference in the 28-day mortality between the hypophosphatemia group and the non-hypophosphatemia group [9.26% (5/54) vs. 11.00% (23/209), P > 0.05]. Multivariate Logistic regression analysis showed that APACHE II score [odds ratio (OR) = 1.188, 95%CI was 1.110-1.271], CRP (OR = 1.016, 95%CI was 1.007-1.026), and NLR (OR = 1.002, 95%CI was 0.996-1.008) were independent risk factors affecting the 28-day mortality of critically ill patients in ICU (all P < 0.05). ROC curve analysis showed that the AUC of serum phosphorus levels for predicting the length of hospital stay of critically ill patients in ICU > 10 days, ICU stay > 5 days, and mechanical ventilation duration > 5 days were 0.701 (95%CI was 0.632-0.770), 0.771 (95%CI was 0.691-0.852), 0.617 (95%CI was 0.541-0.692), respectively, all P < 0.01.

CONCLUSIONS: Hypophosphatemia has some predictive value for the length of hospital and ICU stay and mechanical ventilation time in critically ill patients, but it cannot predict the 28-day mortality.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Jiang J, Bao J, Yang R, et al. [Effect of hypophosphatemia on the prognosis of critically ill patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36177931. doi:10.3760/cma.j.cn121430-20220601-00547

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。